Building Novel DNA Constructs at ASM
News May 14, 2013
Integrated DNA Technologies (IDT) will host a user-orientated product theater presentation at the American Society of Microbiology (ASM) annual meeting (18-21 May, Denver, Colorado).
The presentation entitled ‘Rapid and Reliable Gene Construction with gBlocks™ Gene Fragments and Gibson Assembly™ Method’ will take place on 20 May, 11:00 am - 11:45 am in the Exhibit Hall, booth #1307.
Led by Dr Michel Cannieux, Director of Product Management at IDT, the presentation will offer first hand advice for bench scientists looking to build and modify novel DNA constructs with ease and speed.
Overcoming the costs and inefficiencies associated with traditional PCR techniques for the assembly of novel genes, IDT gBlocks Gene Fragments can be designed up to 500 base pairs and multiple fragments can be easily assembled for the generation of larger gene constructs.
The presentation will guide attendees through this process, offering practical advice for protocols and best practices, while providing insight into the wide range of biological applications and troubleshooting recommendations.
The workshop will give scientists a take-away understanding of how gBlocks can be used to proficiently build novel DNA sequences using the Gibson Assembly Method, in a more cost-effective, dependable manner.
Single-stranded Origami Technology Drives Drug Delivery Systems and Pharmaceutical Nanofactories ForwardNews
First nanotechnological approach enables the design and replication of complex single-stranded DNA and RNA origami with potential for drug delivery and nanofabrication.READ MORE
Cracking the Code of Coenzyme Q BiosynthesisNews
Coenzyme Q is a vital cog in the body’s energy-producing machinery, a kind of chemical gateway in the conversion of food into cellular fuel. Researchers are developing new tools to shed light on CoQ function, primarily by finding and defining proteins that have a direct link to the chemical. This includes the development of a new multi-omic strategy to identify the global function of an RNA-binding protein that has long been associated with mitochondria and its role in CoQ biosynthesis.READ MORE
First Successful Gene Therapy Trial Reported for People with Hemophilia ANews
Patients with hemophilia A who received a single infusion of an investigational gene therapy showed improved levels of the essential blood clotting protein FVIII, with 11 of 13 achieving normal or near-normal FVIII levels.READ MORE